EP 4117781 A1 20230118 - COMPOSITION FOR THE TREATMENT OF LESIONS OF THE RESPIRATORY SYSTEM
Title (en)
COMPOSITION FOR THE TREATMENT OF LESIONS OF THE RESPIRATORY SYSTEM
Title (de)
MITTEL ZUR BEHANDLUNG VON LÄSIONEN DES ATMUNGSSYSTEMS
Title (fr)
COMPOSITION POUR LE TRAITEMENT DE LESIONS DU SYSTEME RESPIRATOIRE
Publication
Application
Priority
- FR 2020000052 W 20200309
- EP 2020073649 W 20200824
- FR 2021050385 W 20210308
Abstract (en)
[origin: WO2021181037A1] The present invention relates to a pharmaceutical composition for use in the prophylaxis and/or treatment of lesions of the respiratory system, in particular lung injuries, caused by a microorganism. The present invention also relates to a pharmaceutical composition for use in the treatment of lesions of the respiratory system, in particular lung injuries, caused by a microorganism. The present invention has an application in particular in the therapeutic, pharmaceutical and veterinary fields.
IPC 8 full level
A61P 11/00 (2006.01); A61K 31/728 (2006.01); A61K 31/737 (2006.01)
CPC (source: EP US)
A61K 31/728 (2013.01 - EP US); A61K 31/737 (2013.01 - EP); A61K 31/795 (2013.01 - US); A61P 11/00 (2017.12 - EP); A61P 31/16 (2017.12 - EP US)
Citation (search report)
See references of WO 2021181037A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2021181037 A1 20210916; AU 2021235223 A1 20220929; CA 3171013 A1 20210916; CN 115209954 A 20221018; CN 115209954 B 20240430; EP 4117781 A1 20230118; JP 2023517579 A 20230426; US 2023113110 A1 20230413
DOCDB simple family (application)
FR 2021050385 W 20210308; AU 2021235223 A 20210308; CA 3171013 A 20210308; CN 202180018759 A 20210308; EP 21717139 A 20210308; JP 2022554312 A 20210308; US 202117910757 A 20210308